A bipartisan group of federal lawmakers introduced a bill on Thursday to remove barriers to conducting research on marijuana. The bill will allow scientists to access cannabis from state-legal dispensaries.
The Medical Marijuana Research Act, filed by Rep. Earl Blumenauer [D-OR] and Rep. Andy Harris [R-MD] would ease the process by which researchers apply for approval to study cannabis and it would place deadlines on federal agencies to consider the applications in a timely manner.
“This legislation would remove barriers for research into cannabis and facilitate access to an increased supply of higher quality medical-grade cannabis for research purposes,” said Blumenauer.
“Congress is hopelessly behind the American people on cannabis, and the quality of our research shows why that is an urgent problem,” Blumenauer told Marijuana Moment. “Despite the fact that 99 percent of Americans live in a state that has legalized some form of cannabis, federal law is still hamstringing researchers’ ability to study the full range of health benefits offered by cannabis, and to learn more about the products readily available to consumers.”
Scientists 'Jumping Through The Hoops'
“Because cannabis is a Schedule I substance, researchers must jump through hoops and comply with onerous requirements just to do basic research on the medical potential of the plant”, Blumenauer said at the House on Thursday.
The Medical Marijuana Research Act amends the Controlled Substances Act to establish a new, separate registration process, specific for marijuana.
Blumenauer explained what the bill would do:
- Streamline the often-duplicative licensure process for researchers seeking to conduct cannabis research;
- Facilitate access to an increased supply of higher quality medical-grade cannabis for research purposes;
- Ensure that research on cannabis and other potentially beneficial marijuana-derived substances is based on sound science;
- Reduce the regulatory barriers associated with marijuana research.
The legislation requires the Drug Enforcement Agency (DEA) to license outside of the National Institute on Drug Abuse (NIDA) to ensure that there is an adequate supply of cannabis products to study.
Representatives Debbie Dingell [D-MI], Steve Cohen [D-TN] Morgan H. Griffith [R-VA], Barbara Lee [D-CA], and Ed Case [D-HI-1], co-sponsored the bill.
Photo: Luis Velzaques - Unsplash
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.